The technique of targeted inactivation of individual genes in mice has undoubtedly revolutionized biomedicine. Applications for gene knockout mice in neuropsychopharmacology are manifold : Determination of targets for established treatments is eased, while development of novel drugs is facilitated for a given target. This review discusses advantages and limitations of gene knockout strategies and, in particular, their relevance for the development of novel diagnostic and therapeutic approaches in psychiatric disorders. In addition to the classical targeted disruption of one or several genes simultanously, it specifically emphasizes those novel techniques that allow the inactivation of a gene with spatio-temporal selectivity.
Introduction
The technique of targeted inactivation of individual genes in mice and its exploitation as a research tool has unquestionably revolutionized biomedicine. Theoretically, the resulting phenotype of a knockout (KO) mouse represents a direct link between the function of a gene product and the whole-animal physiology, including behaviour. This strategy may be applied to almost any gene, making it a universal method of choice to study the function of the ever-increasing number of genes that are being discovered. The previous review by Majzoub and Muglia (1996) has well illustrated the generation of mice with targeted disruption of the corticotropin-releasing hormone (CRH) gene. In brief, the inactivation of a gene is achieved by homologous recombination with a knockout vector in murine embryonic stem (ES) cells. After positive-negative selection of recombinant ES cells and injection of these cells into a developing ovum at the blastocyst stage, they are transferred to a pseudopregnant foster mother. The pups born by this foster mouse are chimeras, with only some cells carrying the deletion. Chimeric offsprings with germline transmission of the recombinant allele are then bred to yield mice heterozygous for the mutant gene and eventually null mutants displaying a complete inactivation of the targeted gene.
These techniques are increasingly under study as potent tools for discovery in psychiatric neuroscience and neuropsychopharmacology. Moreover, advanced insights into the structure and organization of genes, gene promoters, and associated regulatory elements indicate a high degree of modularity and the design of a recombinant transcriptional apparatus that may allow developmental regulation and tissue-restricted expression, in addition to targeted modulation of gene expression by administered drugs in a therapeutic setting : all these are an encouraging perspective of this research. This review describes several aspects of knockout strategies and, in particular, their relevance for the development of novel therapeutic approaches in psychiatric disorders. In addition to the classical targeted disruption of one or several genes, it specifically emphasizes those novel techniques that allow the inactivation of a gene with spatio-temporal selectivity.
Gene targeting in psychiatric neuroscience
Based on remarkable progress in technologies that allow the alteration or elimination of individual genes to create transgenic animal models, constitutive or conditional gene knockout strategies are likely to increase our knowledge of which gene products are involved in the etiopathogenesis of psychiatric disorders. There are evident advantages of having a transgenic model for complex behavioural traits. KO mice may provide unambiguous proof that a particular gene participates in the neuro-and psychopathological processes that occur with these disorders. They also can aid as a system to dissect carefully successive genetic events as well as environmental influences during neurodevelopment and adult brain plasticity that lead to disease states. Based on evidence from replicated linkage and association studies, a multitude of gene variants contributing to inherited psychiatric disorders are likely to be identified in the near future, thus requiring new approaches including knockout strategies to elucidate their pathophysiology.
Knockouts in neuropsychopharmacology
It is obvious that applications for mice with inactivation of a distinct gene are manifold in neuropsychopharmacology. By utilizing this approach, the determination of targets for established treatments is eased or the development of a novel drug may be facilitated for a given target. These specific features prove to be helpful in highly complex neurotransmitter systems in which receptor subtypes are difficult to distinguish using classical pharmacology. In the serotonin (5-HT) system with its complicated neural network and its plethora of receptors, a series of KO mice, each lacking a particular receptor subtype (Saudou et al., 1994 , Tecott et al., 1995 , allows the in vivo receptor profile of a drug to be established more precisely. Elimination of a behavioural or physiological response to a drug when one of several potential sites of action is removed, plausibly indicates that that site is crucial for the response. KO mice are also useful in developing and screening new drugs or novel therapeutic concepts. An example of this are mice with a heterozygous targeted disruption of the 5-HT transporter (5-HTT) Table 1 . Behavioural effects of drugs of abuse in serotonin transporter (5-HTT), dopamine transporter (DAT), and vesicular monoamine transporter (VMAT2) knockout mice
Hyperlocomotion 5 4 7 7 6 Behavioural reward † 7 Cocaine Hyperlocomotion 5 4 7 7 6 Behavioural reward † 5 4 5 4 5 4 6 increased ; 7 decreased ; 7 7 abolished ; 5 4 unchanged ; n.d., not done. * VMAT2 +/− heterozygotes (null mutants die within a few days after birth). † determined by conditioned place preference. " Bengel et al. (1998) . # Giros et al. (1996) . $ Takahashi et al. (1997) . et al. (1997) .
gene, in which only one of the two 5-HTT alleles (5-HTTj\k) has been deleted (Bengel et al., 1998) . These mice show neurochemical changes that partially resemble those observed in humans (and nonhuman primates) carrying low activity alleles of the 5-HTT gene-linked polymorphic region (5-HTTLPR), which may increase the risk of developing depressive illness (Lesch, 1998 ; Bennett et al., manuscript in preparation) . 5-HTTj\k mice could therefore provide a more realistic model to reassess classical treatments for this disorder. Finally, KO mice will also be helpful to study novel therapeutic strategies, including replacement of an artificially inactivated diseaserelated gene (' rescue ' strategies). They will not only aid in the dissection of disease-related pathological processes in brain development and plasticity, but are also likely to serve as a custom-designed system to test therapeutically relevant gene transfer techniques. In line with this thinking, methods of viral-mediated gene transfer to the brain are currently being tested in KO mice lacking a gene of interest, to explore their potential for the treatment of neurodegenerative and other CNS disorders.
As an example for the enormous potential of gene knockout strategies, alterations of MDMA, d-amphetamine, and cocaine-induced behavioural effects in KO mice lacking either the dopamine, 5-HT, or vesicular monoamine transporter, is given in Table 1 . Among a host of complex conclusions drawn from these findings is that MDMA-induced hyperlocomotion is mediated by the 5-HTT and that d-amphetamine exerts locomotor activation primarily via its effect on the dopamine transporter (DAT), while d-amphetamine-induced behavioural reward requires normal functioning of vesicular Knockout mice in neuropsychopharmacology monoamine stores (Giros et al., 1996 ; Wang et al., 1997 ; Takahashi et al., 1997 , Bengel et al., 1998 G. Uhl, personal communication) .
Genetic background
The phenotype of a KO mouse is not only determined by the deleted gene, but also by the complex interaction of a number of genes and their regulatory proteins located close to the locus of the inactivated gene. The ' genetic background ' is of central importance in tests of mouse behaviour. For instance, C57BL\6 mice are the only inbred strain known to perform well in the Morris water maze, however, KO mice are derived from at least two parental strains, substrain 129 of the ES cells and frequently C57BL\6 as donor of the ovum. For tests, especially with behavioural paradigms, it is therefore crucial to ensure that KO mice and their controls have the (' hybrid vigour ') same genetic background. While this will not always be practical for the initial characterization of KO mice, subsequent studies should employ KO mice backcrossed on to a defined genetic background (Table 2 ). An ultimate solution to this issue would be to establish two different backcrosses, one on C57BL\6 and one on another strain, and use the F1 hybrids (C57BL\6iother strain) for behavioural testing. This breeding strategy is highly likely to ensure the elimination of any inbred genetic background that either mitigates, augments, or otherwise complicates the KO phenotype (Banbury Conference, 1997).
Mice with targeted inactivation of two or more genes
Inactivation of a single gene in a functional system may not lead to visible changes, due to counterregulation by other genes during development. In the case of complete compensation of the deficit, mice will only show abnormalities if two genes that complement each other's function are absent. Thus, mice lacking both the 5-HTT and the DAT are likely to respond in different ways to drugs of abuse, compared to mice lacking either the 5-HTT or the DAT. This has led to the concept of double KO mice (DKO), in which two genes have been inactivated. They are derived by crossing two KO lines, each lacking one of the genes. Although studies on DKO mice with a combined inactivation of genes for monoamine synthesizing and metabolizing enzymes as well as monoamine receptors and transporters, are still at an early stage, DKO mice and, as a feasible expansion of this approach, multiple gene KO mice, promise to open up many opportunities to investigate the functional interaction of different proteins within a defined neural system.
Tissue-selective gene knockout
As a consequence of their cell\neuron-selective expression pattern, monoamine transporter KO mice are providing important clues to the function of these proteins (Giros et al., 1996 ; Wang et al., 1997 ; Takahashi et al., 1997 , Bengel et al., 1998 . Many gene products, however, are not restricted to one cell type, but are widely distributed across brain and extraneural tissues. Due to the large number of interacting systems involved, it is frequently difficult to dissect the roles of such a protein by classical knockout techniques. A panel of novel approaches now allow inactivation of mouse genes specifically in selected cell types. In these mice, targeting a gene of interest exclusively in a defined cell type or tissue is achieved by using a bacteriophage recombination system, the so-called Cre\loxP system. Cre is a recombinase, which recognizes loxP, a short DNA sequence containing inverted repeats. If two loxP sites are present in a DNA segment, Cre-mediated recombination will lead to the removal of the loxP flanked DNA segment and thus inactivate the gene (Figures 1B and C) . To ensure tissue specifivity, the cre gene is placed under the control of a cell-selective promoter ( Figure 1A) . In this setting, Cre will be expressed only in the cell type in which the transcriptional machinery recognizes this cell-type specific promoter. The loxP-flanked gene segment will be deleted in these cells, whereas in all other cells, cre will not be transcribed, thus rendering the loxP-flanked gene intact. Among a variety of other tissues, this approach has successfully been used in the CNS. Inactivation of the NMDA receptor NR1 selectively in CA1 pyramidal cells of the hippocampus revealed that this receptor is required for the acquisition of spatial memory (Wilson and Tonegawa, 1997) . A large number of neuronal cellselective promoters of genes, such as the neuron-specific enolase (NSE) and glial acidic-fibrillary protein (GFAP), which are used to express transgenes in neurons and astrocytes, are available for targeting distinct cell populations. On the other hand, neurotransmitter systems like the serotonergic system are being targeted with promoters of the L-tryptophan hydroxylase (L-TPH) or 5-HTT gene (Lesch, 1998) . Since characterization of new gene promoters is accelerating at a remarkable pace, application of these molecular tools will gain even more momentum in the near future to address a host of pertinent problems.
Conditional knockout mice
It has been found that a considerable number of KO mice die during embryonic development or shortly after birth. If a gene is essential for development, it is not possible to study its role in adult mice, using mice with classical gene disruption. To circumvent embryonic death, conditional gene inactivation technologies have been developed. In so-called conditional KO mice, the target gene is deleted at a defined time point. To date, this has been successfully achieved by flanking the targeted gene with loxP sites and delivering Cre via transduction with a recombinant adenoviral vector carrying the cre gene. While the target gene is deleted in virally transduced cells, tissue selectivity may be attained by controlling Cre expression with a selective promoter (Lee et al., 1997 ; Shibata et al., 1997 ; Lesch, 1998) . Other approaches, such as the use of a tetracycline transactivator\operator (tTA\tetO) constructs as a ' genetic switch ', are also extremely promising (Kistner et al., 1996 ; St-Onge et al., 1996) (Figure 2) . Finally, combining both the Cre\loxP system and a modified tTA\tetO technique will be a powerful tool to achieve tight spatio-temporal control of gene expression, a method currently being explored in a study aimed at the conditional inactivation of the presynaptic serotonin1A receptor gene in raphe serotonergic neurons (R. Hen, personal communication). Continued efforts directed at improved understanding of gene organization and gene regulation are likely to lead to further technical refinements in the future. The heuristic potential of these novel gene inactivation techniques for psychiatric neuroscience and neuropsychopharmacology has only begun to be appreciated.
